다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

ATHA

Athira Pharma (ATHA)

Athira Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ATHA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/02	20:00	GlobeNewswire Inc.	Athira Pharma to Participate in Upcoming May Conferences	NASDAQ:ATHA	Athira Pharma Inc
2024/04/15	20:00	GlobeNewswire Inc.	Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer	NASDAQ:ATHA	Athira Pharma Inc
2024/04/11	20:00	GlobeNewswire Inc.	Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease	NASDAQ:ATHA	Athira Pharma Inc
2024/04/03	20:00	GlobeNewswire Inc.	Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting	NASDAQ:ATHA	Athira Pharma Inc
2024/03/08	21:00	GlobeNewswire Inc.	Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference	NASDAQ:ATHA	Athira Pharma Inc
2024/02/23	06:34	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ATHA	Athira Pharma Inc
2024/02/23	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2024/02/23	06:05	GlobeNewswire Inc.	Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:40	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:37	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:32	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ATHA	Athira Pharma Inc
2024/02/09	06:02	GlobeNewswire Inc.	Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/08	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2024/01/08	21:00	GlobeNewswire Inc.	Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update	NASDAQ:ATHA	Athira Pharma Inc
2024/01/03	21:00	GlobeNewswire Inc.	Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease	NASDAQ:ATHA	Athira Pharma Inc
2023/12/12	21:00	GlobeNewswire Inc.	Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies	NASDAQ:ATHA	Athira Pharma Inc
2023/11/29	21:00	GlobeNewswire Inc.	Athira Pharma to Participate in Sidoti December Small Cap Investor Conference	NASDAQ:ATHA	Athira Pharma Inc
2023/11/28	21:00	GlobeNewswire Inc.	Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND	NASDAQ:ATHA	Athira Pharma Inc
2023/11/15	22:15	GlobeNewswire Inc.	Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer’s Disease	NASDAQ:ATHA	Athira Pharma Inc
2023/11/10	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ATHA	Athira Pharma Inc
2023/11/10	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2023/11/10	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc

검색 관련기사 보기:NASDAQ:ATHA

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

JP Morgan Chase

US Dollar vs Euro

Verizon Communications

Invesco QQQ Trust Series 1

BNP Paribas (QX)

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관